FOI 26-2048 – Import Permit Records For Mk–677 & Cjc–1295

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The Department of Health released import permit records for CJC-1295, a synthetic growth hormone-releasing peptide, showing five import authorizations between February and July 2025. One authorization (30 July 2025) was issued under section 47G of the Therapeutic Goods Act, while four earlier permits (24 February through 2 April 2025) lack associated authorization numbers in the disclosed table. CJC-1295 is not approved for therapeutic use in Australia and is typically marketed as a research chemical. The records do not disclose the importer identity, intended use, quantity, or regulatory rationale for the permits. No clinical evaluation, adverse event data, or conditions of import are included in the released excerpt.